Management ChangeJul 15, 2026, 04:18 PM
Mobia Medical Appoints Reza Zadno to Board, Expands Board Size
AI Summary
Mobia Medical, Inc. announced that its Board of Directors increased its size from six to seven members and appointed Reza Zadno, Ph.D., as a new Class III director. Dr. Zadno's term is set to expire at the 2029 annual meeting of stockholders. He was also appointed to the Compensation Committee, replacing Dr. William Harrington, and was determined to be an independent director. Dr. Zadno brings extensive experience, having previously served as CEO of PROCEPT BioRobotics Corporation and Avedro, Inc.
Key Highlights
- Mobia Medical's Board of Directors increased from six to seven members.
- Reza Zadno, Ph.D., was appointed as a new Class III director.
- Dr. Zadno's term as director will expire at the 2029 annual meeting.
- Dr. Zadno was appointed to the Compensation Committee of the Board.
- Dr. William Harrington resigned from the Compensation Committee.
- Dr. Zadno qualifies as an independent director under applicable rules.
- Dr. Zadno previously served as CEO of PROCEPT BioRobotics and Avedro, Inc.
Price Impact
More from MOBI